[Heparanase: target for cancer metastatic therapy].
Zhao
Hua-Jun
HJ
Division of Anti-tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Zhang
Xiong-Wen
XW
Ding
Jian
J
D000818:Animals; D049109:Cell Proliferation / Q000187:drug effects; D015971:Gene Expression Regulation, Enzymologic; D005966:Glucuronidase / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D006801:Humans; D032389:Myocytes, Smooth Muscle / Q000166:cytology; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000098:blood supply / Q000473:pathology*; D009389:Neovascularization, Pathologic / Q000201:enzymology*; D009844:Oligosaccharides / Q000494:pharmacology; D000099175:Heparanase
D005966:Glucuronidase; D009844:Oligosaccharides; D000099175:Heparanase; C120158:phosphomannopentaose sulfate